These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2846508)

  • 1. ECG changes in prolonged treatment of kala-azar with antimony compounds.
    Pandey AK; Kumar M; Thakur CP
    J Assoc Physicians India; 1988 Jun; 36(6):398-9. PubMed ID: 2846508
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-induced ventricular tachycardia in kala-azar.
    Krishnan S; Tuteja A; Gupta HL; Prakash SK
    J Indian Med Assoc; 1987 Feb; 85(2):52-4. PubMed ID: 3039008
    [No Abstract]   [Full Text] [Related]  

  • 3. Complications of kala azar and its treatment in Kenya.
    Chunge CN; Gachihi G; Chulay JD; Spencer HC
    East Afr Med J; 1984 Feb; 61(2):120-7. PubMed ID: 6088210
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged sodium stibogluconate therapy in Indian kala-azar.
    Jha TK; Sharma VK
    J Assoc Physicians India; 1986 Jul; 34(7):469-71. PubMed ID: 3019993
    [No Abstract]   [Full Text] [Related]  

  • 5. Kala-azar: unresponsiveness to prolonged sodium stibogluconate therapy.
    Bhattacharya D; Majhi TK; Dutta RK
    J Assoc Physicians India; 1987 Jul; 35(7):543. PubMed ID: 2828305
    [No Abstract]   [Full Text] [Related]  

  • 6. Cumulative cardiac toxicity of sodium stibogluconate and amphotericin B in treatment of kala-azar.
    Maheshwari A; Seth A; Kaur S; Aneja S; Rath B; Basu S; Patel R; Dutta AK
    Pediatr Infect Dis J; 2011 Feb; 30(2):180-1. PubMed ID: 20823781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harmful effect of high stibogluconate treatment of kala-azar in India.
    Thakur CP
    Trans R Soc Trop Med Hyg; 1986; 80(4):672-3. PubMed ID: 3027929
    [No Abstract]   [Full Text] [Related]  

  • 8. Sodium antimony resistant cases of kala-azar in and around Patna (south Bihar).
    Sehgal PN; Murmu C; Chatteyee AK
    J Commun Dis; 1988 Jun; 20(2):161-2. PubMed ID: 2853714
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypoplasia of bone marrow secondary to sodium antimony gluconate.
    Mallick BK
    J Assoc Physicians India; 1990 Apr; 38(4):310-1. PubMed ID: 2167887
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of visceral leishmaniasis or kala-azar (author's transl)].
    Laroche R; Sirol J; Poli L
    Med Trop (Mars); 1978; 38(4):401-4. PubMed ID: 215868
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal dysfunction in patients of kala azar treated with sodium antimony gluconate.
    Rai US; Kumar H; Kumar U
    J Assoc Physicians India; 1994 May; 42(5):383. PubMed ID: 7829438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium antimony gluconate, amphotericin, and myocardial damage.
    Thakur CP
    Lancet; 1998 Jun; 351(9120):1928-9. PubMed ID: 9654264
    [No Abstract]   [Full Text] [Related]  

  • 13. [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
    Bourée P; Anciaux ML; Taugourdeau P
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):607-10. PubMed ID: 3003657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of visceral leishmaniasis using sodium stibogluconate in a dose of 15 mg antimony/kg body weight twice daily for 30 days: a preliminary report.
    Chunge CN; Gachihi G; Mugambi M; Chulay JD; Spencer HC
    East Afr Med J; 1984 Jul; 61(7):570-4. PubMed ID: 6100588
    [No Abstract]   [Full Text] [Related]  

  • 15. Does antimony therapy cause bleeding in kala-azar patients and why?
    Chowdhury MA; Ahasan HA; Azhar MA; Rafiqueuddin AK; Islam MR; Misbahuddin M; Rashid MU
    Trop Doct; 1995 Oct; 25(4):188-9. PubMed ID: 7502336
    [No Abstract]   [Full Text] [Related]  

  • 16. A thirty day course of sodium stibogluconate for treatment of Kala-azar in Nepal.
    Karki P; Koirala S; Parija SC; Hansdak SG; Das ML
    Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):154-8. PubMed ID: 9740292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate).
    Chulay JD; Spencer HC; Mugambi M
    Am J Trop Med Hyg; 1985 Jul; 34(4):702-9. PubMed ID: 2992303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Indian Kala-azar with pentavalent antimony.
    Domingo P; Ferrer S; Kolle L; Muñoz C; Sambeat MA
    Lancet; 1995 Mar; 345(8949):584-5. PubMed ID: 7776793
    [No Abstract]   [Full Text] [Related]  

  • 19. Deaths in visceral leishmaniasis (Kala-azar) during treatment.
    Ahasan HA; Chowdhury MA; Azhar MA; Rafiqueuddin AK; Azad KA
    Med J Malaysia; 1996 Mar; 51(1):29-32. PubMed ID: 10967976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya.
    Moore E; O'Flaherty D; Heuvelmans H; Seaman J; Veeken H; de Wit S; Davidson RN
    Bull World Health Organ; 2001; 79(5):388-93. PubMed ID: 11417033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.